REMESTYP
Brand:
REMESTYP
Manufacturer:
FERRING
Manufacturer Details
FERRING
Compositions:
Terlipressin 1mg per 10ml injection,
|
Strength
|
Rate
|
Packing Style
|
|
1mg per 10ml
|
2136.00
|
1ml injection
|
List of Related Indications:
List Of Drugs:
- Terlipressin - Bleeding disorders- (July 1996)
Indication Type Description:
Drug Interaction:
Reports not available
Indication:
Control of bleeding oesophageal varices
New Drugs Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Terlipressin acetate 22-07-1996
Finished Formulation
Treatment of bleeding Oseophageal varices
Adverse Reaction:
Refer Vasopression Hyperkaleemia reported in a patient receing terlipressin
Contra-Indications:
Refer Vasopression
Dosages/ Overdosage Etc:
Indication-
Control of bleeding oesophageal varices
Dosage-
Given by intevenous injection in doses of terlipressin acetate 2mg followed by 1 to 2mg every 4 to 6 hours if necessary , until bleeding is controlled, for upt 72 hours
